Nektar Therapeutics (NKTR)
65.92
-2.58
(-3.77%)
USD |
NASDAQ |
Sep 15, 11:15
Nektar Therapeutics 1 Year Total Returns (Daily) : 40.71% for Sept. 14, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 14, 2026 | 40.71% |
| September 11, 2026 | 47.80% |
| September 10, 2026 | 46.64% |
| September 09, 2026 | 50.96% |
| September 08, 2026 | 70.18% |
| September 04, 2026 | 106.2% |
| September 03, 2026 | 167.5% |
| September 02, 2026 | 150.1% |
| September 01, 2026 | 140.3% |
| August 31, 2026 | 139.0% |
| August 28, 2026 | 147.2% |
| August 27, 2026 | 154.6% |
| August 26, 2026 | 156.3% |
| August 25, 2026 | 176.2% |
| August 24, 2026 | 172.6% |
| August 21, 2026 | 164.4% |
| August 20, 2026 | 176.5% |
| August 19, 2026 | 184.7% |
| August 18, 2026 | 168.5% |
| August 17, 2026 | 166.6% |
| August 14, 2026 | 173.6% |
| August 13, 2026 | 195.2% |
| August 12, 2026 | 222.2% |
| August 11, 2026 | 236.0% |
| August 10, 2026 | 224.6% |
| Date | Value |
|---|---|
| August 07, 2026 | 251.6% |
| August 06, 2026 | 227.2% |
| August 05, 2026 | 224.0% |
| August 04, 2026 | 212.7% |
| August 03, 2026 | 207.4% |
| July 31, 2026 | 226.0% |
| July 30, 2026 | 223.7% |
| July 29, 2026 | 208.5% |
| July 28, 2026 | 199.2% |
| July 27, 2026 | 185.4% |
| July 24, 2026 | 187.7% |
| July 23, 2026 | 177.4% |
| July 22, 2026 | 183.2% |
| July 21, 2026 | 177.0% |
| July 20, 2026 | 160.0% |
| July 17, 2026 | 155.9% |
| July 16, 2026 | 177.8% |
| July 15, 2026 | 187.0% |
| July 14, 2026 | 175.2% |
| July 13, 2026 | 173.2% |
| July 10, 2026 | 180.3% |
| July 09, 2026 | 212.2% |
| July 08, 2026 | 216.3% |
| July 07, 2026 | 219.1% |
| July 06, 2026 | 195.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Elite Pharmaceuticals, Inc. | -62.83% |
| Daré Bioscience, Inc. | -65.10% |
| Aclaris Therapeutics, Inc. | 189.2% |
| Eton Pharmaceuticals, Inc. | 226.5% |
| Journey Medical Corp. | 3.80% |